Acute lymphoblastic leukaemia trials in Taiwan
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Taoyuan
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Taipei
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 1/2Taking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Taichung, Taipei
- Age
- 12 years and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - Phase 1/2Taking peopleSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Where
- Taipei
- Age
- 1 year to 30 years
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07387926 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - Phase 1Taking peopleA Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL
- Where
- Taipei
- Age
- 18 years and over
- People
- 12
- Run by
- TriArm Therapeutics (Taiwan) Limited
See details and how to joinNCT07066397